Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-23

Clinical Trial Update: The Efficacy and Safety of Chlorhexidine Gluconate Chip (PerioChip®) in Therapy of Peri-implantitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of Chlorhexidine Gluconate Chip (PerioChip) for peri-implantitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PerioChip (chlorhexidine gluconate chip)

Snippet

Sponsor: Dexcel Pharma Technologies Ltd. | Conditions: Peri-Implantitis | Phase 3 | Status: COMPLETED | Results posted: 2021-06-23